SPRAVATO
LEARN MORE ABOUT SPRAVATO
SPRAVATO is the recently released intranasal ketamine derivative called esketamine.
This is a new method of administering ketamine intranasal instead of Intravenously. It is used in patients for treatment resistant depression, PTSD. It is contraindicated in patients who have psychosis or any psychotic disorders.